Health Catalyst Acquires Carevive, A Leading Oncology-Focused Health Technology Company; No Financial Terms Disclosed

6/6/24 8:38:39 AM ET

Computer Software: Programming Data Processing

Technology

Get the next $HCAT alert in real time by email

Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer.

Get the next $HCAT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HCAT

Date	Price Target	Rating	Analyst
4/10/2024		Overweight → Sector Weight	KeyBanc Capital Markets
1/3/2024	$14.00	Overweight	Barclays
1/3/2024	$11.00	In-line → Outperform	Evercore ISI
12/13/2023	$14.00 → $11.00	Neutral → Overweight	JP Morgan
11/13/2023	$12.00 → $11.00	Neutral → Overweight	Piper Sandler
8/1/2023	$16.00	Overweight	Cantor Fitzgerald
5/10/2023		Outperform → Mkt Perform	Raymond James
5/10/2023		Buy → Neutral	Guggenheim

More analyst ratings

$HCAT
Press Releases

Fastest customizable press release news feed in the world

Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare
SALT LAKE CITY, Nov. 20, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of an AI-powered version of BluePrint Protect™ from Intraprise Health, LLC ("Intraprise Health"), a platform that empowers healthcare organizations to screen and identify risks related to cybersecurity threats through third parties. On Nov. 6, Health Catalyst announced it signed a definitive agreement to acquire Intraprise Health, a tech-enabled cybersecuri
11/20/24 8:30:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences: The Citi 2024 Global Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, and Jason Alger, Chief Financial Officer, on Tuesday, December 3, 2024, at 2:30 pm ET.The 7th Annual Evercore HealthCONx Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, and Jason Alger, Chief Financ
11/19/24 8:00:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the Stephens Annual Investment Conference, being held in Nashville, including a fireside chat on Wednesday, November 20, 2024, at 1:00 pm CT. About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is
11/13/24 8:30:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology

$HCAT
Leadership Updates

Live Leadership Updates

Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors
SALT LAKE CITY, Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jill Hoggard Green, RN, BSN, MS, PhD, FAAN, former Chief Executive Officer of The Queen's Health Systems, has been appointed to serve as a member of Health Catalyst's board of directors ("Board") and a member of its Compensation Committee, effective December 1, 2024. "Jill has been an extraordinary leader throughout her career. With an impressive tenure in hea
11/6/24 4:05:00 PM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive
SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care plan
6/6/24 8:30:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Healthcare Analytics Summit Announces Keynote Speakers for 2024 Event
Dr. Jennifer Doudna, Dr. Michael Pfeffer, Gregory Robinson & More Join HAS 2024 SALT LAKE CITY, Feb. 2, 2024 /PRNewswire/ -- The Healthcare Analytics Summit (HAS), an annual interactive and educational event for the healthcare industry, today announced its keynote and session speaker lineup for the 2024 event. In its tenth year, HAS 24 is the premier event showcasing data and analytics' critical role in tackling some of healthcare's greatest challenges. HAS 24 convenes national experts whose leadership in data and analytics, machine learning, AI, and healthcare technology have
2/2/24 8:30:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology

A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts
In the last three months, 4 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 1 2 0 0 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for Health Catalyst, revealing an average target of $11.5, a high estimate of $14.00, and a low estimate of $8.00. A negative shift in sentiment is evident as a
7/9/24 12:01:12 PM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Evercore ISI Group Maintains Outperform on Health Catalyst, Lowers Price Target to $8
Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and lowers the price target from $9 to $8.
7/9/24 11:05:34 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Health Catalyst, presenting an average target of $13.5, a high estimate of $16.00, and a low estimate of $11.00. Marking an increase of 1.28%, the
6/6/24 10:01:52 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology

Health Catalyst Reports Third Quarter 2024 Results
SALT LAKE CITY, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2024. "For the third quarter of 2024, I am pleased with our strong financial results, including total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, with these results exceeding the mid-point of our quarterly guidance on each metric. This financial performance continues to demonstrate our ability to scale as we remain focused on driving profitable growth. We are encouraged with our bookings results through Q3
11/6/24 4:03:00 PM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024
SALT LAKE CITY, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2024 operating results on Wednesday, November 6, 2024, after market close. In conjunction, the company will host a conference call to review the results at 4:30 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ324." A live audio webcast will be available online at https://ir.healthcatal
10/23/24 8:00:00 AM ET
$HCAT
Computer Software: Programming Data Processing
Technology
Health Catalyst Reports Second Quarter 2024 Results
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024. "For the second quarter of 2024, I am pleased by our strong financial results, including total revenue of $75.9 million and Adjusted EBITDA of $7.5 million, with these results exceeding the mid-point of our quarterly guidance on each metric. I am also pleased with our bookings performance through Q2 2024, especially as it relates to our net new Platform Subscription Clients. In the first half of 2024 we signed more net
8/7/24 4:13:03 PM ET
$HCAT
Computer Software: Programming Data Processing
Technology

Health Catalyst Acquires Carevive, A Leading Oncology-Focused Health Technology Company; No Financial Terms Disclosed

Chat with this insight

Recent Analyst Ratings for $HCAT

$HCAT Press Releases

Fastest customizable press release news feed in the world

Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst to Participate in Upcoming Investor Conference

$HCAT Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Health Catalyst downgraded by KeyBanc Capital Markets

Barclays initiated coverage on Health Catalyst with a new price target

Health Catalyst upgraded by Evercore ISI with a new price target

$HCAT Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief People Officer Llewelyn Linda sold $11,602 worth of shares (1,365 units at $8.50), decreasing direct ownership by 1% to 112,910 units (SEC Form 4)

Chief Operating Officer Lesueur Daniel sold $40,127 worth of shares (5,209 units at $7.70), decreasing direct ownership by 4% to 129,690 units (SEC Form 4)

Chief People Officer Llewelyn Linda sold $10,804 worth of shares (1,324 units at $8.16), decreasing direct ownership by 1% to 114,275 units (SEC Form 4)

$HCAT SEC Filings

Health Catalyst Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Leadership Update, Other Events, Financial Statements and Exhibits

SEC Form D filed by Health Catalyst Inc

SEC Form 10-Q filed by Health Catalyst Inc

$HCAT Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Burton Daniel D. bought $204,525 worth of shares (26,200 units at $7.81), increasing direct ownership by 2% to 1,172,623 units (SEC Form 4)

$HCAT Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

SEC Form SC 13G filed by Health Catalyst Inc

Amendment: SEC Form SC 13G/A filed by Health Catalyst Inc

$HCAT Leadership Updates

Live Leadership Updates

Nationally Recognized Healthcare Executive Dr. Jill Hoggard Green Joins Health Catalyst Board of Directors

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

Healthcare Analytics Summit Announces Keynote Speakers for 2024 Event

$HCAT Market Insights

Live Market Insights

$HCAT Financials

Live finance-specific insights

A Glimpse Into The Expert Outlook On Health Catalyst Through 4 Analysts

Evercore ISI Group Maintains Outperform on Health Catalyst, Lowers Price Target to $8

Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Health Catalyst Reports Third Quarter 2024 Results

Health Catalyst to Announce Third Quarter 2024 Operating Results and Host Conference Call on Wednesday, November 6, 2024

Health Catalyst Reports Second Quarter 2024 Results

Recent Analyst Ratings for
$HCAT

$HCAT
Press Releases

$HCAT
Analyst Ratings

$HCAT
Insider Trading

$HCAT
SEC Filings

$HCAT
Insider Purchases

$HCAT
Large Ownership Changes

$HCAT
Leadership Updates

$HCAT
Market Insights

$HCAT
Financials